此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

无肉、限制酮饮食对身体成分、力量能力、氧化应激、免疫反应的影响

2026年9月21日 更新者:Katarzyna Siedzik

无肉、生酮限制饮食对身体成分、氧化三甲胺 (TMAO) 浓度、血液和尿液中的酮体和葡萄糖、躯体疾病、力量能力、氧化应激、免疫反应的影响

The subject of doctoral dissertation: Assessment of the effects of a meatless, ketogenic restrictive diet on body composition, strength capacity, oxidative stress and immune response

During planning of research and topic of the doctoral dissertation, it was considered how to modify a standard ketogenic diet rich in saturated fatty acids so that the use of this model of nutrition has the most anti-inflammatory effect. Therefore, it was decided to conduct a research to check whether a diet rich in omega-3 polyunsaturated fatty acids will show such an effect when following a high-fat diet.

Hypotheses:

1. The ketogenic diet reduces systemic inflammation. 2.The ketogenic diet reduces oxidative stress. 3. The ketogenic diet reduces body fat. 4. A ketogenic diet does not worsen strength performance.

研究概览

详细说明

a) main research assumption

Reports in the international literature regarding the importance of the ketogenic diet are ambiguous. Some researchers believe that its use reduces body fat and improves insulin sensitivity or lipid profile, while others question this view and question it. Many authors emphasized the need for further research in this area, and this outline of the research project responds to this postulate.

In the presented experiment, the duration of a single experiment was 14 days, because the individual adaptation period of each participant should be taken into account - the so-called "keto-adaptation".

In order to assess the effectiveness of the nutritional intervention in this experiment, the following were performed: blood sampling for the determination of basic parameters (lipid profile, fasting glucose, fasting insulin, diabetic panel, hormones), determination of glucose and ketone bodies (β ketones) in the blood using a strip test - Optium Xido Neo glucometer, determination of the concentration of ketone bodies (acetoacetic acid) and glucose in the urine using Keto-Diastix - a strip test, examination by means of tests - force (maximum isokinetic force test with the use of Biodex apparatus), determination of inflammatory markers (TNF alpha, pro-inflammatory, anti-inflammatory and pro-or anti-inflammatory interleukins depending on the conditions), determination of oxidative stress markers - related to free radical damage to proteins (carbonyl groups, sulfhydryl groups (SH groups)), body composition measurement using the DEXA method (Dual Energy X-ray Absorptiometry). Choosing this method instead of the very common bioimpedance, due to the fact that using densitometry, it obtained very precise results of adipose tissue.

The above-described procedures were used to check the molecular basis of the phenomenon under study, to determine the parameters in which significant changes are visible and to determine the extent to which they translate into the function of the muscle and the subjective feelings of the subject.

Research methodology:

  • body composition (DEXA)- Isometric muscle strength (Biodex)
  • blood tests (lipid profile, glucose, insulin, ketone bodies)
  • inflammatory markers - Luminex method with the use of BioRad BioPlex 200 reader Pro and anti-inflammatory cytokines (Bio-Plex Pro ™ Human Cytokine 8-plex Assay M50000007A, BIO-RAD, USA) (including IFN-y, IL-6, IL-8, IL-10, TNF-a, IL-2, IL-4)
  • metabolic panel - Luminex method with the use of BioRad BioPlex 200 readerm (Bio-Plex Pro ™ Human Diabetes 10-Plex Assay # M171A7001M, BIO-RAD, USA) (including ghrelin, glucagon, insulin, leptin, resistin)
  • markers of oxidative stress - Colorimetric method; Plate-based colorimetric measurement (360-385 nm) (concentration of protein carbonyl groups: Protein Carbonyl Colorimetric Assay Kit No. 100005020 (Cayman Chemical, Ann Arbor, MI, USA)
  • markers of oxidative stress (concentration of protein thiol groups)
  • TMAO (trimethylamine N-oxide)

研究类型

介入性

注册 (实际的)

14

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Greater Poland Voivodeship
      • Poznan、Greater Poland Voivodeship、波兰、61-871
        • Poznan University of Physical Education

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

32年 至 59年 (成人)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • male or female
  • healthy
  • age 32 - 59
  • non-smoker
  • not abusing alcohol
  • not subjected to physical exercise for at least 48 hours before the examination

Exclusion Criteria:

  • cardiovascular,
  • thyroid disease,
  • gastrointestinal,
  • respiratory
  • or any other metabolic diseases adherence to special diets, use of nutritional supplements and use of medication to control blood lipids or glucose

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Meatless restrictive ketogenic diet

Diet was designed to be isoproteic (1.6 g x Kg- 1 x body weight- 1 x day-1) with three meals a day., restrictive (EER minus 500 kcal / day). The distribution of macronutrients during the very low carbohydrate ketogenic diet (KD) was: protein 1.6 g x Kg-1 x body weight- 1 x day-1 (~ 25-30%), fats (~ 65-70%, with a strong emphasis on the content of omega 3 fatty acids) and carbohydrate (< 30 g x day- 1; < 10%).

Each participant received a nutritional plan that was the same qualitatively but differed quantitatively - a 500 kcal reduction based on Estimated Energy Requirement (EER) was assumed. Before the start of the study, each participant obtained information about the basic principles of the ketogenic diet. Diet was designed to be isoproteic (1.6gxKg-1xbody weight-1xday-1) with three meals a day. The distribution of macronutrients during the very low carbohydrate ketogenic diet (KD) was: protein 1.6 gxKg-1xbody weight-1xday-1(~25-30%), fats (~65-70%,with a strong emphasis on the content of omega 3 fatty acids) and carbohydrate (<30gxday-1;<10%).

The food lists encouraged the consumption of fish,raw and cooked vegetables, eggs,fruits with the lowest glycemic index (blueberry, raspberry), plant oils and fats from avocado,olives.Drinks permitted were tea, coffee without sugar and the foods and drinks to be avoided were alcohol,meat (any kind of meat),bread,pasta,rice,milk,dairy and potatoes.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Body composition
大体时间:2 weeks

Whole body and regional body composition were measured in the morning after a 12 hours overnight fast by dual energy X-ray absorptiometry (DEXA) Body Composition: Body Fat Mass, Fat Free Mass, and Visceral Body Fat

Body Fat Mass [Kg] max 40.143 Kg min 11.129 Kg (higher scores mean a worse outcome)

Fat Free Mass [Kg] max 68.527 Kg min 37.72 Kg (higher scores mean a better outcome)

Visceral Body Fat [g] max 2139 g min 90 g (higher scores mean a worse outcome)

2 weeks
Body weight
大体时间:2 weeks

Body weight was measured with an accuracy of 0.1 Kg using an electronic scale (Tanita BC-601, Japan)

Body weight (higher scores mean a worse outcome) [Kg] max 95.7 Kg min 60.9 Kg

2 weeks
TMAO
大体时间:2 weeks

Trimethylamine N-Oxide (measured by Institute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw Poland)

TMAO [ng/ml] (higher scores mean a worse outcome)

2 weeks
Lipids level (TC, HDL, LDL, TG)
大体时间:2 weeks

Level of lipids - (TC- Total Cholesterol, LDL- low-density lipoprotein, HDL- high-density lipoprotein, TG - triacylglycerol)

TC [mg/dl] (higher scores mean a worse outcome) LDL [mg/dl] (higher scores mean a worse outcome) TG [mg/dl] (higher scores mean a worse outcome) HDL [mg/dl] (higher scores mean a better outcome)

2 weeks
glucose level (blood, urine)
大体时间:2 weeks

glucose level (blood, urine) - measured by Ketodiastix and Optimum Xido Neo

higher scores mean a worse outcome

2 weeks
ketone bodies (blood, urine)
大体时间:2 weeks

ketone bodies (blood, urine) - measured by Ketodiastix and Optimum Xido Neo

higher scores mean a better outcome

2 weeks
inflammatory markers
大体时间:2 weeks

inflammatory markers (including IFN-y, IL-6, IL-8, IL-10, TNF-a, IL-2, IL-4) - Luminex method with the use of BioRad BioPlex 200 reader Pro and anti-inflammatory cytokines (Bio-Plex Pro ™ Human Cytokine 8-plex Assay M50000007A, BIO-RAD, USA)

depends - higher scores mean a better or worse outcome

2 weeks
markers of oxidative stress 1
大体时间:2 weeks

markers of oxidative stress - concentration of protein carbonyl groups - Colorimetric method; Plate-based colorimetric measurement (360-385 nm) (concentration of protein carbonyl groups: Protein Carbonyl Colorimetric Assay Kit No. 100005020 (Cayman Chemical, Ann Arbor, MI, USA)

higher scores mean a worse outcome

2 weeks
markers of oxidative stress 2
大体时间:2 weeks

markers of oxidative stress - concentration of protein thiol group

higher scores mean a worse outcome

2 weeks
metabolic panel - diabetes
大体时间:2 weeks

metabolic panel - diabetes (including ghrelin, glucagon, insulin, leptin, resistin) - Luminex method with the use of BioRad BioPlex 200 readerm (Bio-Plex Pro ™ Human Diabetes 10-Plex Assay # M171A7001M, BIO-RAD, USA)

depends - higher scores mean a better or worse outcome

2 weeks
somatic disorders
大体时间:2 weeks

Somatic disorders measured by questionnaire based on Likert's scale

Likert's scale:

  1. - Strongly disagree
  2. - Disagree
  3. - Neither agree nor disagree
  4. - Agree
  5. - Strongly agree

It depends on question - higher scores mean a better or worse outcome

2 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Katarzyna Siedzik, MSc、Poznan University of Physical Education, Poznan, Poland

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2019年10月1日

初级完成 (实际的)

2021年6月30日

研究完成 (实际的)

2022年10月31日

研究注册日期

首次提交

2022年9月23日

首先提交符合 QC 标准的

2022年9月23日

首次发布 (实际的)

2022年9月28日

研究记录更新

最后更新发布 (实际的)

2026年9月24日

上次提交的符合 QC 标准的更新

2026年9月21日

最后验证

2022年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅